Norway vs Türkiye: Hepatitis B surface antigen (HBsAg) prevalence
Norway
0.0%
in 2024
Türkiye
0.0%
in 2024
Norway rank
132nd
Türkiye rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Norway
- Türkiye
How they compare
Norway currently reports 0.0% against 0.0% in Türkiye, a difference of 0.0%.
Across all 10 years both countries report, Türkiye has been ahead every year.
Norway ranks 132nd and Türkiye ranks 132nd of 194 countries.
Türkiye has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | — |
| 2020s | 0.0% | 0.1% | 0.1% | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Norway or Türkiye?
- Norway, at 0.0% against 0.0% in Türkiye as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Norway and Türkiye?
- 0.0%, with Norway ahead.
- How many years of comparable data are there for Norway and Türkiye?
- 10 years are reported by both, from 2015 to 2024.
- How do Norway and Türkiye rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Norway ranks 132nd and Türkiye ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.